Quantification of fibrin degradation products in glioma and meningioma patients

dc.contributor.authorCan, Ozge
dc.contributor.authorErdemgil, Yigit
dc.contributor.authorYildirim, Zeynep Zulfiye
dc.contributor.authorOzduman, Koray
dc.contributor.authorPamir, M. Necmettin
dc.contributor.authorSav, Aydin
dc.contributor.authorOzpinar, Aysel
dc.date.accessioned2025-10-16T15:33:37Z
dc.date.issued2014
dc.identifier.doi10.3233/CBM-140400
dc.identifier.otherWOS:000337916100008
dc.identifier.urihttps://openaccess.acibadem.edu.tr/handle/11443/9270
dc.publisherIOS PRESS
dc.sourceCANCER BIOMARKERS
dc.subjectMeningioma
dc.subjectglioma
dc.subjectfibrin degradation products
dc.subjectDR\\-70
dc.titleQuantification of fibrin degradation products in glioma and meningioma patients
dc.typeArticle

Dosyalar

Koleksiyonlar